Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| NinjaOne | 2026 | Series C | Undisclosed | Austin |
| Nuvation Bio | 2026 | Post-IPO Debt | Undisclosed | New York |
| RQ Bio | 2026 | Series A | Undisclosed | London |
| Baseten | 2026 | Series F | $300.0M | San Francisco |
| Dyne Therapeutics | 2026 | Post-IPO Debt | Undisclosed | Cambridge |
| Moderna | 2026 | Grant | Undisclosed | Cambridge |
| Current | 2026 | Series E | Undisclosed | New York |
| Span | 2026 | Corporate Round | $75.0M | San Francisco |
| 2026 | Post Ipo Debt | $1.0B | San Francisco | |
| Zenas BioPharma | 2026 | Post Ipo Equity | $100.0M | Waltham |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | NinjaOne | Series C | Undisclosed | Austin, United States |
| 2 | Nuvation Bio | Post-IPO Debt | Undisclosed | New York, United States |
| 3 | RQ Bio | Series A | Undisclosed | London, United Kingdom |
| 4 | Baseten | Series F | $300.0M | San Francisco, United States |
| 5 | Dyne Therapeutics | Post-IPO Debt | Undisclosed | Cambridge, United States |
| 6 | Moderna | Grant | Undisclosed | Cambridge, United States |
| 7 | Current | Series E | Undisclosed | New York, United States |
| 8 | Span | Corporate Round | $75.0M | San Francisco, United States |
| 9 | Post Ipo Debt | $1.0B | San Francisco, United States | |
| 10 | Zenas BioPharma | Post Ipo Equity | $100.0M | Waltham, United States |
NinjaOne serves as an IT platform for endpoint management that enhances productivity, minimizes risks, and lowers overall IT expenses.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.
Baseten provides the necessary infrastructure, tooling, and expertise to integrate AI into business operations.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.
Current is a leading consumer fintech banking platform transforming financial access for everyday Americans.
Span develops residential energy storage devices that provide renewable electricity and charging services for electric vehicles.
Pinterest is a visual bookmarking tool for saving and discovering creative ideas.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Quince is an e-commerce company that offers apparel, accessories, home goods, and personal care products through an online platform.
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
Vanta is a trust management platform that automates compliance and risk management.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.
Maza is a mobile app that offers financial products and digital banking services.
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
Lumafield develops industrial computed tomography (CT) solutions for non-destructive testing and inspection for engineers.
PHND is a subscription-free cloud gaming platform for Smart TVs.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Orennia is a technology company focused on the renewable power sector.
Trace Machina is a company that specializes in the development and maintenance of simulation infrastructure.
Mindset assists those with a mental illness and their caregivers in applying for Social Security Disability benefits.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Wellington Management has invested in 167 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Wellington Management's top investment sectors include Health Care, Biotechnology, Software, Pharmaceutical, Medical. The firm invests across 49 different industry categories.
Among tracked funding rounds, Pinterest received $1.0B in a Post Ipo Debt round. Wellington Management's total known invested capital is $36.2B.
Wellington Management's average investment size is $283.1M across its portfolio of 167 companies.
Recent Wellington Management portfolio additions include NinjaOne, Nuvation Bio, RQ Bio, Baseten, Dyne Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors